Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

B′-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase

Open access
Maertens, Goedele N. · 2016 · Nucleic Acids Research

Abstract

To establish infection, a retrovirus must insert a DNA copy of its RNA genome into host chromatin. This reaction is catalysed by the virally encoded enzyme integrase (IN) and is facilitated by viral genus-specific host factors. Herein, cellular serine/threonine protein phosphatase 2A (PP2A) is identified as a functional IN binding partner exclusive to δ-retroviruses, including human T cell lymphotropic virus type 1 and 2 (HTLV-1 and HTLV-2) and bovine leukaemia virus (BLV). PP2A is a heterotrimer composed of a scaffold, catalytic and one of any of four families of regulatory subunits, and the interaction is specific to the B' family of the regulatory subunits. B'-PP2A and HTLV-1 IN display nuclear co-localization, and the B' subunit stimulates concerted strand transfer activity of δ-retroviral INs in vitro. The protein-protein interaction interface maps to a patch of highly conserved residues on B', which when mutated render B' incapable of binding to and stimulating HTLV-1 and -2 IN strand transfer activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkv1347

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. PP2A co-precipitates with BLV and HTLV-1 IN. Colloidal coomassie stained gels of the large scale Flag-IPs done with BLV IN (A) and HTLV-1 IN (B). Bands from the IN and the negative control lanes (indicated with arrows and arrow heads) were excised and analysed in parallel. Migration of the PP2A components is indicated to the right of the gel. Migration of the protein standard (Mark 12, Life Technologies) in kDa is indicated to the left of the gels.
Figure 1. PP2A co-precipitates with BLV and HTLV-1 IN. Colloidal coomassie stained gels of the large scale Flag-IPs done with BLV IN (A) and HTLV-1 IN (B). Bands from the IN and the negative control lanes (indicated with arrows and arrow heads) were excised and analysed in parallel. Migration of the PP2A components is indicated to the right of the gel. Migration of the protein standard (Mark 12, Life Technologies) in kDa is indicated to the left of the gels.CC BY · PubMed Central
Figure 2. The interaction between PP2A and IN is genus-specific. (A) Flag-IP of transiently expressed Flag-tagged BLV and HTLV-1 IN in HEK293T cells. This is not a composite image; the vertical line was added to delineate the border between input and IP samples. *Degradation product of Cα. (B) Flag-IP using INs from different retroviral genera stably expressed in HEK293T cells. As a negative control, the parental cell line was used. Retroviral genus is indicated above the blot. Antibodies used are indicated to the right of the blot. **Degradation product of PFV IN.
Figure 2. The interaction between PP2A and IN is genus-specific. (A) Flag-IP of transiently expressed Flag-tagged BLV and HTLV-1 IN in HEK293T cells. This is not a composite image; the vertical line was added to delineate the border between input and IP samples. *Degradation product of Cα. (B) Flag-IP using INs from different retroviral genera stably expressed in HEK293T cells. As a negative control, the parental cell line was used. Retroviral genus is indicated above the blot. Antibodies used are indicated to the right of the blot. **Degradation product of PFV IN.CC BY · PubMed Central
Figure 3. HTLV-1 IN binds directly to the B′ regulatory subunit. (A) NiNTA pull-downs using hexahistidine tagged HTLV-1 and -2 or FIV IN as bait. Five micrograms of bait and B′γ(11–380) were used. Input and pull-down samples are indicated above the gel. (B) B′δ(76–501) binds to HTLV-1 IN but not to HIV-1 IN. NiNTA pull-downs as described in (A). Migration of B′δ(76–501) and the IN proteins is indicated to the right of the gel. Lane 1: input of B′δ(76–501), lane 2: pull-down using HIV-1 IN-His6 as bait, lane 3: pull-down using HTLV-1 IN-His6 as bait. (C) NiNTA pull-down with either no IN (negative control) or HTLV-1 IN-His6 as bait. Addition of B″, or B′γ(11–380) to the pull-downs is indicated above the gel. The input of B″ was originally loaded on a different gel; the vertical line illustrates the border between the two gels. (D) Three isoforms of B′: B′γ(11–380), B′δ(76–501) and B′ϵ(51–401), and the scaffold subunit Aα were tested for binding to HTLV-1 and HTLV-2 IN-His6 by NiNTA pull-down. No IN was added in the negative control samples. The input of Aα was originally loaded on a different gel; the vertical line illustrates the border between the two gels. Input and pull-down are indicated above the gel. Migration of the proteins is indicated to the right of the gels. Migration of the molecular weight marker (in kDa) is indicated to the left of the gel. All gels were stained with Coomassie.
Figure 3. HTLV-1 IN binds directly to the B′ regulatory subunit. (A) NiNTA pull-downs using hexahistidine tagged HTLV-1 and -2 or FIV IN as bait. Five micrograms of bait and B′γ(11–380) were used. Input and pull-down samples are indicated above the gel. (B) B′δ(76–501) binds to HTLV-1 IN but not to HIV-1 IN. NiNTA pull-downs as described in (A). Migration of B′δ(76–501) and the IN proteins is indicated to the right of the gel. Lane 1: input of B′δ(76–501), lane 2: pull-down using HIV-1 IN-His6 as bait, lane 3: pull-down using HTLV-1 IN-His6 as bait. (C) NiNTA pull-down with either no IN (negative control) or HTLV-1 IN-His6 as bait. Addition of B″, or B′γ(11–380) to the pull-downs is indicated above the gel. The input of B″ was originally loaded on a different gel; the vertical line illustrates the border between the two gels. (D) Three isoforms of B′: B′γ(11–380), B′δ(76–501) and B′ϵ(51–401), and the scaffold subunit Aα were tested for binding to HTLV-1 and HTLV-2 IN-His6 by NiNTA pull-down. No IN was added in the negative control samples. The input of Aα was originally loaded on a different gel; the vertical line illustrates the border between the two gels. Input and pull-down are indicated above the gel. Migration of the proteins is indicated to the right of the gels. Migration of the molecular weight marker (in kDa) is indicated to the left of the gel. All gels were stained with Coomassie.CC BY · PubMed Central
Figure 4. B′γ stimulates δ-retroviral strand transfer activity of HTLV-1 and -2 IN. (A) Scheme explaining concerted versus half-site integration (23). Whereas insertion of one donor DNA substrate into the supercoiled plasmid DNA results in an open circular form of DNA (half-site integration) (left), concerted integration of two donor DNA molecules results in a linear strand transfer product (right). (B) and (C) Donor DNA mimicking the 3′-processed ends was used (S20P for HTLV-1 IN and S30P for HTLV-2 IN). Presence of donor DNA, B′γ(11–380), HTLV-1 IN (B) or HTLV-2 IN (C) and tDNA (pGEM9zf(-)) are indicated above the gel. (B) Integration assays with HTLV-1 IN. Concentration of proteins used: in the absence of B′γ(11–380): lanes 1, 2, 8, 9 and 12: 4 μM IN; lanes 3 and 10: no IN; lane 4: 1 μM IN; lane 5: 2 μM IN; lane 6: 4 μM IN; lane 7: 6 μM IN. Lanes 12–16 were done in the presence of 4 μM IN with the following concentration of B′γ(11–380): lane 12: 0 μM B′; lane 13: 0.25 μM B′; lane 14: 0.5 μM; lane 15: 1 μM, lane 16: 2 μM. Lane 11 was done in the absence of IN and presence of 2 μM B′γ(11–380). (C) Integration assays with HTLV-2 IN. In the absence of B′γ(11–380): lanes 1 and 2: 4 μM IN; lane 3: no IN; lane 4: 1 μM IN; lane 5: 2 μM IN; lane 6: 4 μM IN. Lanes 7–10 were done using 1 μM HTLV-2 IN and the following concentrations of B′γ(11–380): lane 7: 0.25 μM; lane 8: 0.5 μM; lane 9: 1 μM and lane 10: 2 μM. DNA products were separated on a 1.5% agarose gel and stained with GelRed. Migration of DNA species in the gel is indicated on the right of the gel. S.c., supercoiled; o.c., open circular. The 1 kb DNA ladder (NEB, indicated on the left of the gel) was used as a reference. This is a representative of experiments repeated four times (HTLV-1 IN) and three times (HTLV-2 IN). For quantification, S20PQ (HTLV-1 IN) (D) and S24PQ (HTLV-2 IN) (E) were used as donor DNA. Strand transfer activity was quantified as published earlier (21). A standard curve was made using reactions done with HTLV IN: B′γ in a 2:1 molar ratio and strand transfer products were quantified in relation to this standard curve. Fold stimulation of integration activity was determined by calculating the increase in product compared to the reactions done in the absence of B′γ. Bar plots were made by calculating the averages and standard deviations of three independent experiments.
Figure 4. B′γ stimulates δ-retroviral strand transfer activity of HTLV-1 and -2 IN. (A) Scheme explaining concerted versus half-site integration (23). Whereas insertion of one donor DNA substrate into the supercoiled plasmid DNA results in an open circular form of DNA (half-site integration) (left), concerted integration of two donor DNA molecules results in a linear strand transfer product (right). (B) and (C) Donor DNA mimicking the 3′-processed ends was used (S20P for HTLV-1 IN and S30P for HTLV-2 IN). Presence of donor DNA, B′γ(11–380), HTLV-1 IN (B) or HTLV-2 IN (C) and tDNA (pGEM9zf(-)) are indicated above the gel. (B) Integration assays with HTLV-1 IN. Concentration of proteins used: in the absence of B′γ(11–380): lanes 1, 2, 8, 9 and 12: 4 μM IN; lanes 3 and 10: no IN; lane 4: 1 μM IN; lane 5: 2 μM IN; lane 6: 4 μM IN; lane 7: 6 μM IN. Lanes 12–16 were done in the presence of 4 μM IN with the following concentration of B′γ(11–380): lane 12: 0 μM B′; lane 13: 0.25 μM B′; lane 14: 0.5 μM; lane 15: 1 μM, lane 16: 2 μM. Lane 11 was done in the absence of IN and presence of 2 μM B′γ(11–380). (C) Integration assays with HTLV-2 IN. In the absence of B′γ(11–380): lanes 1 and 2: 4 μM IN; lane 3: no IN; lane 4: 1 μM IN; lane 5: 2 μM IN; lane 6: 4 μM IN. Lanes 7–10 were done using 1 μM HTLV-2 IN and the following concentrations of B′γ(11–380): lane 7: 0.25 μM; lane 8: 0.5 μM; lane 9: 1 μM and lane 10: 2 μM. DNA products were separated on a 1.5% agarose gel and stained with GelRed. Migration of DNA species in the gel is indicated on the right of the gel. S.c., supercoiled; o.c., open circular. The 1 kb DNA ladder (NEB, indicated on the left of the gel) was used as a reference. This is a representative of experiments repeated four times (HTLV-1 IN) and three times (HTLV-2 IN). For quantification, S20PQ (HTLV-1 IN) (D) and S24PQ (HTLV-2 IN) (E) were used as donor DNA. Strand transfer activity was quantified as published earlier (21). A standard curve was made using reactions done with HTLV IN: B′γ in a 2:1 molar ratio and strand transfer products were quantified in relation to this standard curve. Fold stimulation of integration activity was determined by calculating the increase in product compared to the reactions done in the absence of B′γ. Bar plots were made by calculating the averages and standard deviations of three independent experiments.CC BY · PubMed Central
Figure 5. HTLV-1 and -2 IN are active on blunt substrates. Integration reactions done with HTLV-1 or HTLV-2 IN using either blunt (B) or pre-processed (P) donor DNA as substrate. Reactions were allowed to take place at 37°C for 90 min before the reactions were stopped. (A) Reactions done with HTLV-1 IN. All reactions (except for lane 3 where IN was omitted) contained 4 μM HTLV-1 IN and 2 μM B′γ(11–380). Lane 1: no donor, lane 2: no tDNA; lane 3: no IN; lane 4: blunt donor; lane 5: pre-processed donor. (B) Reactions with HTLV-2 IN. Donor DNA of different lengths were used as indicated above the gel. All reactions (except for lane 3 where IN was omitted) contained 1 μM HTLV-2 IN and 0.5 μM B′γ(11–380). Lane 1: no donor, lane 2: no tDNA; lane 3: no IN; lane 4: blunt donor DNA 19-mer; lane 5: pre-processed 19-mer; lane 6: blunt 24-mer; lane 7: pre-processed 24-mer; lane 8: blunt 30-mer and lane 9: pre-processed 30-mer. DNA products were separated on a 1.5% agarose gel and stained with GelRed. Migration of DNA species in the gel is indicated on the right of the gel. S.c. supercoiled; o.c., open circular. The 1 kb DNA ladder (NEB, indicated on the left of the gel) was used as a reference. Gels representative of three independent experiments are shown. (C) Products of concerted integration catalysed by HTLV-1 or -2 IN in the presence of B′ (2:1 molar ratio) were cloned and sequenced. Percentage of 6 bp duplication, other duplications and deletions are shown in pie charts. Fourty four clones were sequenced for HTLV-1 IN and 38 for HTLV-2 IN.
Figure 5. HTLV-1 and -2 IN are active on blunt substrates. Integration reactions done with HTLV-1 or HTLV-2 IN using either blunt (B) or pre-processed (P) donor DNA as substrate. Reactions were allowed to take place at 37°C for 90 min before the reactions were stopped. (A) Reactions done with HTLV-1 IN. All reactions (except for lane 3 where IN was omitted) contained 4 μM HTLV-1 IN and 2 μM B′γ(11–380). Lane 1: no donor, lane 2: no tDNA; lane 3: no IN; lane 4: blunt donor; lane 5: pre-processed donor. (B) Reactions with HTLV-2 IN. Donor DNA of different lengths were used as indicated above the gel. All reactions (except for lane 3 where IN was omitted) contained 1 μM HTLV-2 IN and 0.5 μM B′γ(11–380). Lane 1: no donor, lane 2: no tDNA; lane 3: no IN; lane 4: blunt donor DNA 19-mer; lane 5: pre-processed 19-mer; lane 6: blunt 24-mer; lane 7: pre-processed 24-mer; lane 8: blunt 30-mer and lane 9: pre-processed 30-mer. DNA products were separated on a 1.5% agarose gel and stained with GelRed. Migration of DNA species in the gel is indicated on the right of the gel. S.c. supercoiled; o.c., open circular. The 1 kb DNA ladder (NEB, indicated on the left of the gel) was used as a reference. Gels representative of three independent experiments are shown. (C) Products of concerted integration catalysed by HTLV-1 or -2 IN in the presence of B′ (2:1 molar ratio) were cloned and sequenced. Percentage of 6 bp duplication, other duplications and deletions are shown in pie charts. Fourty four clones were sequenced for HTLV-1 IN and 38 for HTLV-2 IN.CC BY · PubMed Central
Figure 6. (A) Cartoon representation created in Pymol of B′γ1 (PDB 2IAE) (27) showing the pseudo-HEAT repeats in different colours, and labelled above the repeats as HEAT 1–8. The brackets on top of the cartoon refer to the deletion mutants designed to express HEAT repeats 1–3 (B′γ (11–194)) and 4–8 (B′γ(195–380). (B) Schematic representation of the pseudo-HEAT repeats in B′γ. The deletion mutants and point mutants used in this work are drawn underneath the full length (FL) protein. Start and end residues of the deletion fragments are indicated. Residue(s) indicated in red, blue and black are respectively critical, important and not involved in the interaction with HTLV-1 and -2 IN. (C) Ni-NTA pull-down done as described in Figure 3. Binding of B′γ(11–380), B′γ(11–194) and B′γ(195–380) to HTLV-1 IN-His6 was tested. Input and pull-downs are indicated above the gels. Migration of B′γ deletion fragments and HTLV-1 IN-His6 is indicated to the right of the gel. Migration of the molecular weight marker (in kDa) is indicated to the left of the gel. All gels were stained with Coomassie.
Figure 6. (A) Cartoon representation created in Pymol of B′γ1 (PDB 2IAE) (27) showing the pseudo-HEAT repeats in different colours, and labelled above the repeats as HEAT 1–8. The brackets on top of the cartoon refer to the deletion mutants designed to express HEAT repeats 1–3 (B′γ (11–194)) and 4–8 (B′γ(195–380). (B) Schematic representation of the pseudo-HEAT repeats in B′γ. The deletion mutants and point mutants used in this work are drawn underneath the full length (FL) protein. Start and end residues of the deletion fragments are indicated. Residue(s) indicated in red, blue and black are respectively critical, important and not involved in the interaction with HTLV-1 and -2 IN. (C) Ni-NTA pull-down done as described in Figure 3. Binding of B′γ(11–380), B′γ(11–194) and B′γ(195–380) to HTLV-1 IN-His6 was tested. Input and pull-downs are indicated above the gels. Migration of B′γ deletion fragments and HTLV-1 IN-His6 is indicated to the right of the gel. Migration of the molecular weight marker (in kDa) is indicated to the left of the gel. All gels were stained with Coomassie.CC BY · PubMed Central
Figure 7. B′γ R197, L237 and P238 are critical for the interaction with HTLV-1 IN. (A) Flag-IPs with HTLV-1 IN-Flag and HA-tagged B′γ(11–380) wild type and point mutants as indicated above the gel. Antibodies used are indicated to the right of the blots. This is not a composite figure; the vertical line was added as a border between input and IP samples. (B) Coomassie stained gel of Ni-NTA pull-downs using HTLV-1 IN-His6 or HTLV-2 IN-His6 as bait, with wild type and B′γ(11–380) point mutants as indicated above the gel. (C–E) B′γ(11–380) point mutants unable to bind to HTLV IN do not stimulate concerted integration activity. (C) Reactions for HTLV-1 IN. All lanes, except lane 1 where donor was omitted, have donor DNA (pre-processed 20-mer). Lane 2: no tDNA, lane 3: no IN or B′γ(11–380), lane 4: no B′γ(11–380). Concentrations for HTLV-1 IN and B′γ(11–380) are as follows: 4 μM HTLV-1 IN with either 0.25 μM, 0.5 μM or 1 μM B′γ(11–380) WT or mutants was used in the reactions as indicated above the gel. (D) Reactions for HTLV-2 IN. All lanes, except lane 1 where donor was omitted, have donor DNA (pre-processed 24-mer). Lane 2: no tDNA, lane 3: no IN or B′γ(11–380). Lane 4; no B′γ(11–380), lanes 4–19 1 μM HTLV-2 IN. Lanes 5–7; 8–10; 11–13; 14–16; 17–19: respectively, 0.125 μM, 0.25 μM and 0.5 μM of WT, mutant 5, mutant 8, mutant 9 or mutant 10 B′γ(11–380) as indicated above the gels. Reactions were done for 1 h at 37°C. DNA products were separated on a 1.5% agarose gel and stained with GelRed. The 1 kb DNA ladder (NEB, indicated to the left of the gel) was used as a reference. (C) and (D) are not composite images; vertical lines were added in between the reactions done with different B′γ mutants to simplify the image. (E) Reactions were done as described above. Products of concerted integration were quantified as described previously (21) using the molar ratio of 2:1 IN : B′γ. Donor S20PQ and S24PQ were used for HTLV-1, respectively, HTLV-2 IN. A standard curve was made by serial dilution of the condition using WT B′γ. Fold stimulation is expressed in comparison to the reactions with WT B′γ, arbitrarily set to 100%. Averages and standard deviations are shown calculated on the data obtained from three independent experiments.
Figure 7. B′γ R197, L237 and P238 are critical for the interaction with HTLV-1 IN. (A) Flag-IPs with HTLV-1 IN-Flag and HA-tagged B′γ(11–380) wild type and point mutants as indicated above the gel. Antibodies used are indicated to the right of the blots. This is not a composite figure; the vertical line was added as a border between input and IP samples. (B) Coomassie stained gel of Ni-NTA pull-downs using HTLV-1 IN-His6 or HTLV-2 IN-His6 as bait, with wild type and B′γ(11–380) point mutants as indicated above the gel. (C–E) B′γ(11–380) point mutants unable to bind to HTLV IN do not stimulate concerted integration activity. (C) Reactions for HTLV-1 IN. All lanes, except lane 1 where donor was omitted, have donor DNA (pre-processed 20-mer). Lane 2: no tDNA, lane 3: no IN or B′γ(11–380), lane 4: no B′γ(11–380). Concentrations for HTLV-1 IN and B′γ(11–380) are as follows: 4 μM HTLV-1 IN with either 0.25 μM, 0.5 μM or 1 μM B′γ(11–380) WT or mutants was used in the reactions as indicated above the gel. (D) Reactions for HTLV-2 IN. All lanes, except lane 1 where donor was omitted, have donor DNA (pre-processed 24-mer). Lane 2: no tDNA, lane 3: no IN or B′γ(11–380). Lane 4; no B′γ(11–380), lanes 4–19 1 μM HTLV-2 IN. Lanes 5–7; 8–10; 11–13; 14–16; 17–19: respectively, 0.125 μM, 0.25 μM and 0.5 μM of WT, mutant 5, mutant 8, mutant 9 or mutant 10 B′γ(11–380) as indicated above the gels. Reactions were done for 1 h at 37°C. DNA products were separated on a 1.5% agarose gel and stained with GelRed. The 1 kb DNA ladder (NEB, indicated to the left of the gel) was used as a reference. (C) and (D) are not composite images; vertical lines were added in between the reactions done with different B′γ mutants to simplify the image. (E) Reactions were done as described above. Products of concerted integration were quantified as described previously (21) using the molar ratio of 2:1 IN : B′γ. Donor S20PQ and S24PQ were used for HTLV-1, respectively, HTLV-2 IN. A standard curve was made by serial dilution of the condition using WT B′γ. Fold stimulation is expressed in comparison to the reactions with WT B′γ, arbitrarily set to 100%. Averages and standard deviations are shown calculated on the data obtained from three independent experiments.CC BY · PubMed Central
Figure 8. B′γ residues involved in binding to HTLV-1 IN are highly conserved and orient away from the substrate binding site. (A) Surface representation of the B′-PP2A holoenzyme based on PDB: 2IAE (27). The scaffold subunit (Aα) is shown in orange, the catalytic subunit (Cα) in yellow and the B′ regulatory subunit in brown. Residues involved in binding to HTLV-1 IN are shown as sticks and coloured as follows: carbon, green; oxygen, red; nitrogen, blue. The active site, at the interface between B′γ and Cα, is indicated. (B) Residues involved in binding to HTLV-1 and -2 IN (highlighted with green boxes) are highly conserved. Alignment of HEAT repeats 4 and 5 of human B′γ regulatory subunit (Hs_B′γ, GI: 31083259) with human B′α (Hs_B′α, GI: 5453950), B′β (Hs_B′β, GI: 5453952), B′δ (Hs_B′δ, GI: 5453954), B′ϵ (Hs_B′ϵ, GI: 5453956), bovine B′γ (Bos taurus, Bt_B′γ, GI: 134085946), and B′ isoforms from Saccharomyces cerevisiae (Sc_Rts1p, GI: 532526), Schizosaccharomyces pombe (Sc_B′, GI: 19075706), Caenorhabditis elegans (Ce_B′, GI: 17557914), Drosophila melanogaster (Dm_B′, GI: 60677747) and Arabidopsis thaliana (At_B′, GI: 2244898). Numbers in brackets indicate the residue number of the respective isoform at which the alignment starts. Numbers on top of the alignment correspond to residue numbers in the human B′γ isoform. Secondary structures indicated are based on PDB: 2IAE (27). Alignments were made in Clustal Omega (53) (http://www.ebi.ac.uk/Tools/msa/clustalo/) and the figure was prepared using Espript 3.x (54) (http://espript.ibcp.fr/ESPript/ESPript/). For alignment with all bovine B′ regulatory subunits, see Supplementary Figure S7.
Figure 8. B′γ residues involved in binding to HTLV-1 IN are highly conserved and orient away from the substrate binding site. (A) Surface representation of the B′-PP2A holoenzyme based on PDB: 2IAE (27). The scaffold subunit (Aα) is shown in orange, the catalytic subunit (Cα) in yellow and the B′ regulatory subunit in brown. Residues involved in binding to HTLV-1 IN are shown as sticks and coloured as follows: carbon, green; oxygen, red; nitrogen, blue. The active site, at the interface between B′γ and Cα, is indicated. (B) Residues involved in binding to HTLV-1 and -2 IN (highlighted with green boxes) are highly conserved. Alignment of HEAT repeats 4 and 5 of human B′γ regulatory subunit (Hs_B′γ, GI: 31083259) with human B′α (Hs_B′α, GI: 5453950), B′β (Hs_B′β, GI: 5453952), B′δ (Hs_B′δ, GI: 5453954), B′ϵ (Hs_B′ϵ, GI: 5453956), bovine B′γ (Bos taurus, Bt_B′γ, GI: 134085946), and B′ isoforms from Saccharomyces cerevisiae (Sc_Rts1p, GI: 532526), Schizosaccharomyces pombe (Sc_B′, GI: 19075706), Caenorhabditis elegans (Ce_B′, GI: 17557914), Drosophila melanogaster (Dm_B′, GI: 60677747) and Arabidopsis thaliana (At_B′, GI: 2244898). Numbers in brackets indicate the residue number of the respective isoform at which the alignment starts. Numbers on top of the alignment correspond to residue numbers in the human B′γ isoform. Secondary structures indicated are based on PDB: 2IAE (27). Alignments were made in Clustal Omega (53) (http://www.ebi.ac.uk/Tools/msa/clustalo/) and the figure was prepared using Espript 3.x (54) (http://espript.ibcp.fr/ESPript/ESPript/). For alignment with all bovine B′ regulatory subunits, see Supplementary Figure S7.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 2

  1. 10.1042/bj3530417 · DOI · Paper page
  2. 10.1128/mcb.11.8.4282 · doi:10.1128/mcb.11.8.4282

Cited by

See all 38

Metadata

Authors
Maertens, G. N.
Affiliations
Imperial College London (GB)
Corresponding author
Maertens, Goedele N.
Venue
Nucleic Acids Research
Published
2015-12-10
Volume
44
Issue
1
Pages
364-376
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2180564665
Cited by
38
References
55
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 6 · 2016: 2
FWCI
1.97
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
  • Wellcome Trust (/Z/15/Z, 107005/Z/15/Z)
  • Imperial College London
  • University of Oxford
  • Centro Nacional de Pesquisa em Energia e Materiais
  • Laboratório Nacional de Biociências
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
protein phosphatase 2A, bovine leukemia virus, protein-protein interfaces, retroviral integration, host factors
MeSH terms
Amino Acid Sequence, Animals, Leukemia Virus, Bovine, Carrier Proteins, Cattle, Cell Line, Enzyme Activation, Humans, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Human T-lymphotropic virus 1, Sequence Alignment, Virus Integration, Deltaretrovirus, Integrases, Protein Subunits, Protein Interaction Mapping, Protein Phosphatase 2, Protein Interaction Domains and Motifs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: B′-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase. https://app.cochat.ai/papers/10.1093/nar/gkv1347
The paper
Maertens, G. N. (2016). B′-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase. Nucleic Acids Research. https://doi.org/10.1093/nar/gkv1347

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.